These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23970897)

  • 1. Metabolic and clinical consequences of hyperthyroidism on bone density.
    Gorka J; Taylor-Gjevre RM; Arnason T
    Int J Endocrinol; 2013; 2013():638727. PubMed ID: 23970897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Thyroid Pathology on Osteoporosis and Fracture Risk: A Review.
    Apostu D; Lucaciu O; Oltean-Dan D; Mureșan AD; Moisescu-Pop C; Maxim A; Benea H
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32156092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of thyroid diseases on bone].
    Tsourdi E; Lademann F; Siggelkow H
    Internist (Berl); 2018 Jul; 59(7):661-667. PubMed ID: 29744522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid Hormone Diseases and Osteoporosis.
    Delitala AP; Scuteri A; Doria C
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
    Földes J; Lakatos P; Zsadányi J; Horváth C
    Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthyroidism, thyroid hormone therapy, and bone.
    Ross DS
    Thyroid; 1994; 4(3):319-26. PubMed ID: 7833670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association.
    Hong AR; Kang HC
    Endocrinol Metab (Seoul); 2023 Apr; 38(2):175-189. PubMed ID: 37150514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The skeletal consequences of thyrotoxicosis.
    Nicholls JJ; Brassill MJ; Williams GR; Bassett JH
    J Endocrinol; 2012 Jun; 213(3):209-21. PubMed ID: 22454529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies.
    Yang R; Yao L; Fang Y; Sun J; Guo T; Yang K; Tian L
    J Bone Miner Metab; 2018 Mar; 36(2):209-220. PubMed ID: 28357593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density in hyperthyroidism.
    Karga H; Papapetrou PD; Korakovouni A; Papandroulaki F; Polymeris A; Pampouras G
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):466-72. PubMed ID: 15473879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population.
    Lee K; Lim S; Park H; Woo HY; Chang Y; Sung E; Jung HS; Yun KE; Kim CW; Ryu S; Kwon MJ
    Osteoporos Int; 2020 Mar; 31(3):547-555. PubMed ID: 31720711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of thyroid disorders on the bone].
    Mikosch P
    Wien Med Wochenschr; 2005 Oct; 155(19-20):444-53. PubMed ID: 16425000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women.
    Belaya ZE; Melnichenko GA; Rozhinskaya LY; Fadeev VV; Alekseeva TM; Dorofeeva OK; Sasonova NI; Kolesnikova GS
    Hormones (Athens); 2007; 6(1):62-70. PubMed ID: 17324919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time.
    Olkawa M; Kushida K; Takahashi M; Ohishi T; Hoshino H; Suzuki M; Ogihara H; Ishigaki J; Inoue T
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):171-6. PubMed ID: 10396358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism].
    Yang LJ; Shen FX; Zheng JC; Zhang HL
    Zhongguo Gu Shang; 2012 Feb; 25(2):133-7. PubMed ID: 22577718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of thyroid disorders on bone density and biochemical markers of bone metabolism.
    Tsevis K; Trakakis E; Pergialiotis V; Alhazidou E; Peppa M; Chrelias C; Papantoniou N; Panagopoulos P
    Horm Mol Biol Clin Investig; 2018 Sep; 35(1):. PubMed ID: 30218603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
    Földes J; Tarján G; Szathmari M; Varga F; Krasznai I; Horvath C
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):521-7. PubMed ID: 8252739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristics of osteoporotic patients in Graves' disease patients newly diagnosed after menopause: a prospective observational study.
    Yoshihara A; Yoshimura Noh J; Mukasa K; Watanabe N; Iwaku K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Endo K; Suzuki R; Hattori N; Sugino K; Ito K
    Endocr J; 2016 Dec; 63(12):1113-1122. PubMed ID: 27600197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormones: beneficial or deleterious for bone?
    Lakatos P
    Calcif Tissue Int; 2003 Sep; 73(3):205-9. PubMed ID: 14667131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.